Language
Search
News
- Bruker Introduces High Definition (HD) and the revolutionary NMR Thermometer™ to NMR with the Most...
- Bruker Anounces BNL, a Nitrogen Re-Liquefaction Accessory for More Efficient, Sustainable and...
- New CryoProbe™ Prodigy TCI 600 Delivers a 2.5x Proton Sensitivity Boost, Providing a more than...
- Bruker Announces Acquisition of SkyScan, a Leading Provider of Micro-CT Systems for 3D X-Ray...
- Bruker Expands Cooperation with Aspect Imaging on High-Performance Desktop MRI System for...
Pharmaceutical Reseach
Toxicology screening using NMR
The later that a molecule or molecular class is lost from the drug development pipeline, the higher the financial cost. Minimizing attrition is therefore one of the most important aims of a pharmaceutical discovery programme. Novel technologies that increase the probability of making the right choice early save resources, and promote safety, efficacy and profitability. Metabolomics is a systems approach for studying in vivo metabolic profiles, which promises to provide information on drug toxicity, disease processes and gene function at several stages in the discovery and-development process.

